Corrigendum
In the January 2006 issue, the footnote to Table 1 was published as “aN-terminal pro-brain natriuretic peptide has yet to be approved by the FDA for risk-stratification purposes in acute coronary syndromes”. This should have appeared as “aN-terminal pro-brain natriuretic peptide has been approved by the FDA for risk-stratification purposes in acute coronary syndromes and recently also for risk-stratification purposes in patients with stable coronary artery disease”.
Additional information
The online version of the original article can be found at 10.1038/ncpcardio0405
Rights and permissions
About this article
Cite this article
Maisel, A., Bhalla, V. & Braunwald, E. Erratum: Cardiac biomarkers: a contemporary status report. Nat Rev Cardiol 3, 288 (2006). https://doi.org/10.1038/ncpcardio0514
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0514